Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record.

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate

Buchbinder, Rachelle, Barber, Melissa, Heuzenroeder, Louise, Wluka, Anita E., Giles, Graham, Hall, Stephen, Harkness, Andrew, Lewis, Daniel, Littlejohn, Geoff, Miller, Marian H., Ryan, Peter F. J., Jolley, Damien·2008·Arthritis Care & Research

Abstract

Objective: To determine cancer risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with methotrexate in community practice. Methods: All RA patients who started methotrexate prior to June 1986 and were attending 1 of 6 rheumatologists were studied. Demographic data were matched to the State Cancer Registry to identify all malignancies (except nonmelanoma skin cancer) for 1983–1998, and to the National Death Index to identify all deaths to the end of 1999. Followup started on the date when methotrexate was started and ended either on the last confirmed date on which the patient was seen by the rheumatologist or at death. Standardized incidence ratios (SIRs) were calculated using state population cancer rates stratified by sex, age (in 5‐year groups), and calendar year. Results: There were 4,145 person‐years of followup (average 9.3 years). Eighty‐seven malignancies were identified (14 before, 64 during, and 9 after the followup period). There was an estimated 50% excess risk of malignancy among methotrexate‐exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2–1.9), with a 3‐fold increase in melanoma (SIR 3.0, 95% CI 1.2–6.2), a 5‐fold increase in non‐Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2–10.0), and an almost 3‐fold increase in lung cancer (SIR 2.9, 95% CI 1.6–4.8). Conclusion: Compared with the general population, methotrexate‐treated RA patients have an increased incidence of melanoma, non‐Hodgkin's lymphoma, and lung cancer. There may be a role for regular skin cancer screening for all RA patients, particularly those receiving immunosuppressive therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.23716

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 217

Metadata

Authors
Buchbinder, R., Barber, M., Heuzenroeder, L., Wluka, A. E., Giles, G., Hall, S., Harkness, A., Lewis, D., Littlejohn, G., Miller, M. H., Ryan, P. F. J., & Jolley, D.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2008-05-30
Volume
59
Issue
6
Pages
794-799
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W2005490856
Cited by
217
References
0
FWCI
8.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. https://app.cochat.ai/papers/10.1002/art.23716
The paper
Buchbinder, R., Barber, M., Heuzenroeder, L., Wluka, A. E., Giles, G., Hall, S., Harkness, A., Lewis, D., Littlejohn, G., Miller, M. H., Ryan, P. F. J., & Jolley, D. (2008). Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Care & Research. https://doi.org/10.1002/art.23716

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.